A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin 2, and interferon alpha-2B in patients with metastatic melanoma.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples